Nissan Creates New Technology That Can "Inactivate" Viruses


Nissan has announced that it has collaborated with Tohoku University's Faculty of Pharmaceutical Sciences to develop a new virus-inactivating technology.

According to the release, the collaboration leverages "Nissan’s technologies and expertise in automotive development, and the Tohoku University faculty’s technologies related to drug development, drug evaluation, and other pharmaceutical sciences, catalyst preparation, and catalyst performance evaluation."

Organic nitroxyl radical oxidation catalysts, often known as radical catalysts, are used in the technology. They are employed as additives in automobile paint polymer base materials, as well as fiber and organic polymer materials used in car interiors and exteriors.

Radiant catalysts in Nissan vehicles inhibit photodegradation processes such cracking, embrittlement, and fading over long periods of time. The carmaker has been exploring and developing alternative applications for radical catalysts in order to maximize their catalytic activity and contribute to society.

In the case of viruses, radical catalysts inactivate them by oxidizing organic molecules, or more precisely, by inactivating the spike protein, preventing it from adhering to a human cell.

According to the research, the technique works on the SARS-CoV2 (omicron strain). A feline coronavirus was also investigated and shown to be effective as an alternative SARS-CoV2 virus. It also acts in the dark at room temperature without requiring light irradiation, as is typical with oxidation.

Nissan claims that this technology can also kill diseases like fungus and germs. The business also anticipates a wide range of potential possibilities for the technology. These include antibacterial and antiviral base ingredients in air conditioning and air purifier filters. They can also be utilized in medical masks and fabrics.


Post a Comment

Previous Post Next Post